The insulin-like growth factor-I system and hormone replacement therapy.
Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.
Estrogen, progesterone and the gastrointestinal tract.
Acquired dermal melanocytosis in an African-American: A case report.
A case of a pregnant woman with luteal insufficiency and a mutation in the beta-subunit of luteinizing hormone.
Reading level of drug information printouts: A barrier to effective communication of patient medication information.
(Principles of hormone replacement therapy in the menopause.)
Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda.
Effects of estrogen replacement isolated and associated with gestrinone in oophorectomized adult rats with experimental endometriosis.
Experience with growth hormone therapy in Turner syndrome in a single centre: Low total height gain, no further gains after puberty onset and unchanged body proportions.
The effect of hormone replacement therapy on CYP3A activity.
Prescription medication costs: A study of physician familiarity.
Radical toxicity of phenols: A reference point for obtaining perspective in the formulation of QSAR.
Pharmacogenomic determinants of plasma PAl-1 level in healthy post-menopausal women.
Increases in autoantibody Titer to low density lipoprotein modified by malondialdehyde in postmenopausal cynomolgus macaques treated with medroxyprogesterone acetate can be accounted for by increases in plasma insulin.
Abnormal uterine bleeding: Diagnostic considerations, management options.
Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Influence of hormone replacement therapy and aspirin on temperature regulation in postmenopausal women.
Route-dependent endocrine and metabolic effects of estrogen replacement therapy.
Recruitment of participants for the Estrogen Replacement and Atherosclerosis (ERA) trial: A comparison of costs, yields, and participant characteristics from community- and hospital-based recruitment strategies.
Evidence that a metabolite of equine estrogens, 4-hydroxyequilenin, induces cellular transformation in vitro.
Mutagenic properties of estrogen quinone-derived DNA adducts in simian kidney cells.
Sex hormones and headache.
Hormone replacement therapy in postmenopausal women with diabetes mellitus: A risk-benefit assessment.
Glycaemic control and hormone replacement therapy: Implications of the Postmenopausal Estrogen/Progestogen Intervention (PEPI) Study.
Menopause and treatments.
Effect of low-dose estrogen on hemodynamic response to stress.
Two years follow-up of bleeding pattern during continuous HRT in recent postmenopausal women with uterine myomas.
Cell cycle analysis and detection of proliferating cell nuclear antigen of the endometrium after hormone replacement therapy.
Polycystic ovary syndrome: New perspective on an old problem.
B cell subsets in postmenopausal women and the effect of hormone replacement therapy.
Sex differences in androgen receptors of the human mamillary bodies are related to endocrine status rather than to sexual orientation or transsexuality.
Androgen deficiency in women with hypopituitarism.
Effects of synthetic progestin on nitric oxide bioactivity and markers of inflammation in overweight postmenopausal women.
Fibrinolytic potentiation by hormone replacement therapy at conventional dosage in healthy postmenopausal women is independent of tissue factor activation.
(Medicamentous therapy for constitutional macrosomatia.)
Menopause.
The endometrium and hormone replacement: Safety and bleeding.
The effects of hormone replacement therapy on plasma homocysteine levels in healthy postmenopausal women.
Vaginal flora, pH and hormonal colpocytology in post-menopausal women during estrogen replacement therapy.
Hormonal therapy and tamoxifen effects on adrenal, pancreas and thyroid of oophorectomized adult rats.
The long term effects of cyclic-combined conjugated estrogens and dydrogesterone for the treatment of postmenopausal women.
Improved amenorrhea favorable vasomotor and lipid effects, and endometrial safety with lower doses of conjugated estrogens (CE) and medroxyprogesterone acetate (MPA).
Temporal lobe epilepsy in rats: Influence of replacement therapy.
Training physical program and HRT: Beneficial effect in menopausal symptomatic and sedentary women.
Clinical effects of low-dose continuous combined conjugated estrogen and medroxyprogesterone therapy in postmenopausal women.
Bleeding patterns in postmenopausal women using two types of continuous combined hormone replacement therapy.
Effects of estrogen therapy and gestrinone in oophorectomized adult rats with experimental endometriosis.
(Ureteral obstruction due to postmenopausal endometriosis.)
(Does the conjugated estrogen (Premarin) accelerate coronary and uterine bleeding experimentally?)
Hormone replacement therapy in postmenopausal women: Endometrial hyperplasia and irregular bleeding.
Introduction.
The importance of patient education in improving compliance.
The need for continuing education of the prescriber.
